Tissue removal is currently the only way to verify suspicious lesions in the prostate. It is also a key requirement before treating prostate carcinomas. The standard biopsy is performed with transrectal ultrasound (TRUS) to guide the needle in the right direction.
Agfa HealthCare has released the latest version of its IMPAX HeartStation, a comprehensive management system for electrocardiograms (ECGs). Built on standards-based architecture, the system supports most existing and new ECG devices, integrating easily with the legacy hospital and clinic IT infrastructure and ECG workflow, Agfa reports.
Shenzhen, China - The China International Medicinal Equipment Fair (CMEF), held this April was founded in 1979. In its 30-year existence this bi-annual event (spring/autumn) has become the biggest exhibition of medical equipment, related products and services in the Asia-Pacific region.
Surgeons using technology-supported surgical systems, e.g. lasers and robotics, are challenged not to lose sight of the human element, which influenced the theme Humanity through technology for the 126th Annual Congress of the German Society for Surgery (DGCH) held in Munich this April.
Seoul, S. Korea - This March, European Hospital was present at the Korea International Medical and Hospital Equipment Show (Kimes), our fifth time at this special event.
In April, the 75th annual congress of the German Cardiac Society (DGK) was considered a great success, drawing in some 7,900 specialists.
At Euromedlab (7-11 June, Austria), Beckman Coulter will demonstrate the new UniCel DxH 800 Coulter Cellular Analysis System.
Although the majority of the 18,000 participants at ECR 2009 were radiologists, medical writer Rob Skelding reports that a specific session for radiographers was well attended. The event also underlined the value of their interpretive skills
A new technology that dramatically improves the sensitivity of Magnetic Resonance techniques including those used in hospital scanners and chemistry laboratories has been developed by scientists at the University of York.
At ECR healthcare manufacturers not only introduced the latest products, but also the future technologies and trends that will have an impact on the market in the coming years.
Results of five clinical studies evaluating the predictive value of VENDYS, a new FDA-approved cardiovascular test, were presented at the 2009 Annual Scientific Sessions of the American College of Cardiology in Florida.
Tuttlingen Municipal Clinic occupies two sites, the result of merger in 2002 of two clinics in Tuttlingen and Spaichingen, following a merger of the two clinics in Tuttlingen and Spaichingen in 2002.
Stephan Sagolla (56) is the new global managing director of the BERCHTOLD Group in Tuttlingen. Before joining BERCHTOLD, the internationally experienced manager held various executive positions in the healthcare and medical engineering sectors.
Ten years ago, New York real estate entrepreneur Israel Green began a worldwide search for a cure for his wife´s lung cancer. A year later, the couple returned to New York empty handed. Just days before a risky surgery, they were happily stunned to be given a very different diagnosis: acid reflux.
Depending on the institution, CT examination doses can vary dramatically by a factor of ten, said Professor John Damilakis, PhD, associate professor at the University of Crete, Iraklion, ahead of the session. The difference is related principally to variations in the examination technique, as the protocol or the imaging system itself determines the level of radiation.
New possibilities in breast ultrasound comprise techniques for optimizing image quality such as tissue harmonic imaging (THI) and frequency compounding (FC), tools for post-processing US raw data such as strain imaging (elastography), and the use of Realtime-Sonoelastography, PD Dr. Anke Thomas from the Charité in Berlin, Germany, introduced her speech at the Hitachi Symposium Realtime Tissue…
One of the most exciting innovations to be presented at this year's ECR (European Congress of Radiology), was be Viamo™. This pioneering product from Toshiba Medical Systems Europe is the first to offer premium technology in an ultraportable ultrasound system without compromising image quality or ease of use.
Within the last three decades, contrast-enhanced magnetic resonance breast imaging has gone through substantial developments, evolving to become the imaging modality with the highest sensitivity for breast cancer detection. The indication to perform breast MRI ranges widely, including high-risk patients, dense breast tissue and therapy monitoring under primary systemic therapy.
Delegates at the 2009 European Congress of Radiology (ECR) saw a series of presentations Friday unveiling new findings and key updates on digital breast tomosynthesis (DBT). As the body of research builds in this relatively unexplored field, the advantages and limitations of DBT compared with conventional full-field digital mammography (FFDM) and other modalities are becoming better defined.
Toshiba's pre-opening ECR event on Wednesday evening attracted around 120 radiological experts who wanted to learn more about the company's technology in daily practice. Toshiba invited several highly-regarded radiologists and cardiologists from Austria and Germany who not only presented the diagnostic possibilities of the firm's products offers, but answered critical questions asked by the…
EH correspondent David Loshak reports
The multichannel tips are also packaged in new cases that simplify handling and storage and facilitate recycling.
The Russian Healthcare market has always been lucrative for European medical technology companies.
With 16 years’ experience in developing contrast media power injectors, Medtron AG recently launched the Accutron HP-D, which, the firm reports, is the only totally wireless, high pressure double-head injector dedicated to all vascular diagnostic and interventional procedures.
Current procedures are still imprecise and speculative; without a subsequent biopsy suspicious PSA levels, images and the results of palpation cannot be correctly evaluated. Thus there is an energetic pursuit to discover new imaging technologies. Dr Thilo Eggert at the Urological Clinic of the Ruhr University Bochum at the Marienhopital Herne, is among the investigators.
